TGC Ventures International, Inc. (TGVN) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Distribution industria. La empresa tiene su sede en Atlanta, GA, United States. El CEO actual es Michael Woo.
TGVN tiene fecha de IPO 2014-11-03, cotiza en el Other OTC, una capitalización de mercado de $120.00.
TGC Ventures International, Inc. operates early detection cancer clinics, using infra-red thermal imaging technology. The technology is used as diagnosis to determine structure changes in tissues to detect breast cancer. The company was formerly known as National Detection Clinics, Ltd. and changed its name to TGC Ventures International, Inc. in December 2005. TGC Ventures International, Inc. was incorporated in 2003 and is headquartered in Atlanta, Georgia.
